Clonazepam Tablet, Orally Disintegrating
Product Images NDC 49884-310

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 49884-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is The Structural Formula. (Clonazepam Tablet Orally Disintegrating 1)

FDA Label Image

Clonazepam Odt, Usp 0.5 mg (Blister)

This is a description of Clonazepam orally disintegrating tablets with a strength of 0.5 mg. The tablets are intended for oral use and are produced by PAR Pharmaceutical Companies Inc. in Spring Valley, NY. The tablets contain Phenylalanine at a concentration of 0.56 mg per tablet. The tablets should not be pushed and are not suitable for individuals with PKU (Phenylketonuria). The rest of the text is related to the batch number and manufacturing information.*

FDA Label Image

Clonazepam Odt, Usp 1 mg (Blister)

Clonazepam Orally Disintegrating Tablet, USP is a medication manufactured by PAR PHARMACEUTICAL COS, INC. The tablet is dissolved orally and contains Phenylalanine. The text contains a warning not to push the tablet for Phenylketonurics. The medication is labeled with a batch number and expiration date.*

FDA Label Image

Clonazepam Odt, Usp 2 mg (Blister)

This is a medication called Clonazepam, in orally disintegrating tablet form. It contains an ingredient called Phenylalanine, which is 0.56mg per tablet and is not suitable for people with Phenylketonurics. It is manufactured by PAR Pharmaceutical located in Spring Valley, NY. The medication is identified by NDC number: 003 49884-310-52 3 and lot number BL310-83-1-05 RO5/16.*

FDA Label Image

This Is The 0.125 mg Carton (Clonazepam Tablet Orally Disintegrating 13)

This is a medicine bottle containing Clonazepam Orally disintegrating tablets with 0.125mg strength. It has the NDC number 49884-306-02 and comes with a medication guide for each patient. The bottle has 60 tablets, divided into 10 blister cards with 6 tablets each. There are additional text blocks that are not readable to provide a full description.*

FDA Label Image

This Is The 0.25 mg Carton. (Clonazepam Tablet Orally Disintegrating 14)

This is a prescription medication guide for Clonazepam orally disintegrating tablets, USP. The package contains 60 tablets in 10 blister cards of 6 tablets each, with a concentration of 0.25 mg. The National Drug Code (NDC) for this product is 49884-307-02. The text also includes some unclear characters and does not provide additional relevant information.*

FDA Label Image

This Is The 0.5 mg Carton (Clonazepam Tablet Orally Disintegrating 15)

This is a medication packaging label for Clonazepam disintegrating tablets. The label includes the National Drug Code (NDC) number, dosage strength, quantity, and instructions for the pharmacist to dispense as prescribed medication only. The label mentions a medication guide that should be provided to each patient. Additionally, there are some non-English characters and random text which are not useful.*

FDA Label Image

This Is The 1 mg Carton (Clonazepam Tablet Orally Disintegrating 16)

Clonazepam is a medication used to treat seizures and panic attacks. It comes in the form of orally disintegrating tablets, each containing 1mg of Clonazepam. The package contains 60 tablets, distributed into 10 blister cards, each containing 6 tablets. The NDC code for this package is 49884-309-02. The package contains a medication guide for each patient.*

FDA Label Image

This Is The 2 mg Carton (Clonazepam Tablet Orally Disintegrating 17)

This text contains information about a medication called Clonazepam, which comes in the form of orally disintegrating tablets. The medication is intended for dispensing by a pharmacist upon a patient's prescription. It requires the pharmacist to dispense medication guidance with each patient. The package contains blister cards with each card containing 6 tablets and a total of 60 tablets. There is additional text that appears to be in another language and cannot be evaluated.*

FDA Label Image

This Is 0.125 mg Picture Of Pills. (Clonazepam Tablet Orally Disintegrating 2)

The text "0.125 mg front and back" suggests that there might be a medication or supplement that is dosed at 0.125 milligrams, and it may have directions to take it both on the front and back of the packaging. However, without additional information, it is not possible to determine what the medication or supplement is for, or any other details about its use.*

FDA Label Image

This Is 0.25 mg Picture Of Pills. (Clonazepam Tablet Orally Disintegrating 3)

FDA Label Image

This Is 0.5 mg Picture Of Pills. (Clonazepam Tablet Orally Disintegrating 4)

FDA Label Image

This Is 1 mg Picture Of Pills. (Clonazepam Tablet Orally Disintegrating 5)

FDA Label Image

This Is 2 mg Picture Of Pills. (Clonazepam Tablet Orally Disintegrating 6)

FDA Label Image

This Is The Civ Image (Clonazepam Tablet Orally Disintegrating 7)

FDA Label Image

Clonazepam Odt, Usp 0.125 mg (Blister)

This is a description for Clonazepam Orally Disintegrating Tablet, USP (0.125 mg). The tablet is manufactured by PAR Pharmaceutical Cos., Inc. in Spring Valley, NY. Each tablet contains Phenylalanine (0.56mg), for which people with Phenylketonuria should be cautious. The tablet should not be pushed. The information is repeated throughout the document with slight variations but no significant differences.*

FDA Label Image

Clonazepam Odt, Usp 0.25 mg (Blister)

This is a description of Clonazepam Orally Disintegrating Tablet, USP manufactured by Par Pharmaceutical Cos., Inc. The tablet contains Phenylalanine 0.56 mg per tablet and is not suitable for people with Phenylketonuria. The tablet should not be pushed. The location of the manufacturer is Spring Valley, NY 10977. The product code is BL307-83-1-05 RO5/16. The rest of the text is not readable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.